Trades on 2 secondary markets

Avalynpharma

Avalyn Pharma is a clinical-stage biotechnology company developing inhaled therapies for rare and serious respiratory diseases, with a focus on idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases. Its inhaled-delivery pipeline includes AP01 (inhaled pirfenidone), AP02 (inhaled n

minimal 14.6 / 100 0 APIs View provider profile →

Company Biotechnology Pharmaceuticals Clinical Stage Respiratory Pulmonary Fibrosis

Avalynpharma is an API provider whose private shares are listed on 2 secondary markets: Hiive, EquityZen.

Where It Trades

H Hiive View listing → EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.